You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cabometyx

Showing 1 - 25 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

d To Treat People With Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Cancer
  • Tokyo, Japan
    Takeda Selected Site
Dec 5, 2022

d To Treat People With Renal Cell Carcinoma

Recruiting
  • Renal Cell Carcinoma
  • Tokyo, Japan
    Takeda Selected Site
Apr 26, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 3, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • +3 more
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Esophageal Cancer, Metastatic Cancer, Squamous Cell Carcinoma Trial in Taipei City (Cabozantinib 40 MG, Atezolizumab Injection)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Cabozantinib 40 MG
  • Atezolizumab Injection
  • Taipei City, Taiwan
    National Taiwan University Hospital
Sep 15, 2022

Meningioma Trial in Miami (Cabozantinib)

Recruiting
  • Meningioma
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
Jun 17, 2022

Metastatic Renal Cell Carcinoma Treated With Cabozantinib Trial in Durham, Raleigh (Usability of an electronic symptom

Terminated
  • Metastatic Renal Cell Carcinoma Treated With Cabozantinib
  • Usability of an electronic symptom management application
  • Durham, North Carolina
  • +1 more
Jun 10, 2021

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)

Recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Kansas City, Kansas
  • +3 more
May 12, 2023

Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

Terminated
  • Cervical Cancer
  • +3 more
  • Cabozantinib 40 MG oral once a day
  • Pembrolizumab 200 mg IV every 3 weeks
  • Mobile, Alabama
    University of South Alabama Mitchell Cancer Institute
Jun 3, 2022

High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

Recruiting
  • High Grade Neuroendocrine Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 11, 2021

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Hepatocellular Carcinoma, HCC Trial in Orange (Nivolumab, Ipilimumab, Cabozantinib)

Recruiting
  • Hepatocellular Carcinoma
  • HCC
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)

Completed
Has Results
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 29, 2021

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

Not yet recruiting
  • Neuroendocrine Tumors
  • Portland, Oregon
    Providence Portland Cancer Institute - Franz Clinic
Feb 10, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Cancer Trial in Heidelberg, Mainz (combination of Avelumab and Cabozantinib)

Recruiting
  • Cancer
  • combination of Avelumab and Cabozantinib
  • Heidelberg, Germany
  • +1 more
Mar 31, 2022

Advanced Metastatic Melanoma Trial in Iowa City (Cabozantinib, Pembrolizumab)

Recruiting
  • Advanced Metastatic Melanoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021